AARC Supports Protection of Patents
March 30, 2009
Patent reform legislation is moving through Congress now, and the AARC is joining with fellow organizations to urge key members of the Senate to consider the need to protect medically-related patents in the process.
Noting patents drive funding for research into new treatments and modalities, the letter states, “If a patent’s value can be diminished, or a patent can be challenged on a broad range of grounds…we know investors will back away. With small companies accounting for two-thirds of the future clinical pipeline, we know you will share our concern that patent reform does not have the unintended consequence of drying up a huge portion of potential products and our greatest hope for better treatments and interventions.”
The letter went out last week to members of the influential Senate Judiciary Committee and was signed by 30 health related organizations.